Back
Inhibrx Biosciences, Inc. Vs. Liquidia Corp. Industry Stock Comparison
Sell
46
INBX
Inhibrx Biosciences, Inc.
Last Price:
$72.98
Seasonality Move:
-17.56%
Buy
73
LQDA
Liquidia Corp.
Last Price:
$35.81
Seasonality Move:
2.66%
Sell
46
Inhibrx Biosciences, Inc. (INBX)
is a Sell
Is Inhibrx Biosciences, Inc. a Buy, Sell or Hold?
-
The current Inhibrx Biosciences, Inc. [INBX] share price is $72.86. The Score for INBX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Liquidia Corp. (LQDA)
is a Buy
Is Liquidia Corp. a Buy, Sell or Hold?
-
The current Liquidia Corp. [LQDA] share price is $35.86. The Score for LQDA is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
LQDA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INBX Stock Price Chart
What is Inhibrx Biosciences, Inc.'s stock price today?
-
The Inhibrx Biosciences, Inc. share price today is $72.86Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX is experiencing selling pressure, which indicates risk of future bearish movement.
LQDA Stock Price Chart
What is Liquidia Corp.'s stock price today?
-
The Liquidia Corp. share price today is $35.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LQDA is experiencing slight buying pressure.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.08 | Sell |
| Relative Strength Index (14 RSI): | 40.13 | Sell |
| Chaikin Money Flow: | -81447 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.51 - 86.71) | Sell |
| Bollinger Bands (100): | (30.62 - 81.32) | Buy |
LQDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 60.45 | Buy |
| Chaikin Money Flow: | 3787275 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.52 - 35.3) | Buy |
| Bollinger Bands (100): | (23.58 - 32.26) | Buy |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.65 | Sell |
| 20-day SMA: | 79.9 | Sell |
| 50-day SMA: | 80.65 | Sell |
| 200-day SMA: | 35.93 | Buy |
| 8-day EMA: | 76.45 | Sell |
| 20-day EMA: | 78.8 | Sell |
| 50-day EMA: | 73.9 | Sell |
| 200-day EMA: | 45.29 | Buy |
LQDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.14 | Buy |
| 20-day SMA: | 33.84 | Buy |
| 50-day SMA: | 30.92 | Buy |
| 200-day SMA: | 21.83 | Buy |
| 8-day EMA: | 33.31 | Buy |
| 20-day EMA: | 33.27 | Buy |
| 50-day EMA: | 31.17 | Buy |
| 200-day EMA: | 23.7 | Buy |
Inhibrx Biosciences, Inc. Earnings Growth & INBX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.25 per share, and an increase next year of $2.01 per share.
Liquidia Corp. Earnings Growth & LQDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.17 per share, and an increase next year of $0.25 per share.
Inhibrx Biosciences, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Liquidia Corp. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||